Skip to main content
TipRanks
Go Ultimate75% OFF

Zevra Therapeutics (ZVRA) Income Statement

1,159 Followers

Zevra Therapeutics Income Statement

Last quarter (Q3 2026), Zevra Therapeutics's total revenue was $37.76M, an increase of 44.86% from the same quarter last year. In Q3, Zevra Therapeutics's net income was $19.21M. See Zevra Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 106.47M$ 23.61M$ 27.46M$ 10.16M$ 28.65M
$ 89.99M$ 16.20M$ 24.52M$ 9.94M$ 26.59M
$ 94.22M$ 103.20M$ 74.12M$ 52.50M$ 18.86M
Depreciation and Amortization$ 4.05M$ 6.39M$ 1.01M$ 944.00K$ 257.00K
$ 98.71M$ -76.40M$ -43.54M$ -25.53M$ -7.89M
$ -4.23M$ -87.00M$ -49.60M$ -42.56M$ 7.73M
$ 90.91M$ -3.14M$ 3.56M$ 15.76M$ -16.25M
$ 86.68M$ -90.14M$ -46.05M$ -26.80M$ -8.52M
$ 83.23M$ -105.51M$ -46.05M$ -26.77M$ -8.55M
Per Share Metrics
Basic EPS$ 1.40$ -2.28$ -1.30$ -0.78$ -2.11
Diluted EPS$ 1.35$ -2.28$ -1.30$ -0.78$ -2.11
Weighted Average Shares Outstanding55.31M46.25M35.45M34.49M29.77M
Weighted Average Shares Outstanding (Diluted)57.26M46.25M35.45M34.49M29.77M

Currency in USD

Zevra Therapeutics Earnings and Revenue History

-120M0120M240M-500 %-250 %0 %250 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin